Pharmacokinetic Study to Determine Time to Steady-State of an Oral Testosterone Undecanoate Formulation in Hypogonadal Men.

Trial Profile

Pharmacokinetic Study to Determine Time to Steady-State of an Oral Testosterone Undecanoate Formulation in Hypogonadal Men.

Completed
Phase of Trial: Phase II

Latest Information Update: 18 Aug 2010

At a glance

  • Drugs Testosterone undecanoate (Primary)
  • Indications Hypogonadism
  • Focus Pharmacokinetics
  • Most Recent Events

    • 18 Aug 2010 Actual end date added to 1 Jan 2010 as reported by ClinicalTrials.gov.
    • 18 Aug 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
    • 04 Sep 2009 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top